AlphaStocks
5.3
Consider Buy

ANI PHARMACEUTICALS INC (ANIP)

Health Care / Pharmaceuticals

S&P SmallCap 600

$82.85

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

#439out of 1121 in Health Care

Is ANI PHARMACEUTICALS INC a Good Investment in 2026?

ANI PHARMACEUTICALS INC (ANIP) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates ANI PHARMACEUTICALS INC as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 92%). ANI PHARMACEUTICALS INC currently trades below its estimated fair value of $107, suggesting potential upside. ANI PHARMACEUTICALS INC ranks #439 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E22.4ROE13.3Market Cap2B

Estimated Fair Value

$106.8822% below

Fair value above market price. P/E of 22x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

72% above fair value

Lynch

Strong

PEG 0.7 · Fast Grower

Greenblatt

Caution

Bottom half (rank 92%)

Frequently Asked Questions

Is ANI PHARMACEUTICALS INC (ANIP) a good investment?
Based on AlphaStocks' composite analysis, ANI PHARMACEUTICALS INC (ANIP) scores 5.3 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Fair value above market price. P/E of 22x is moderate for this quality level.
What is ANI PHARMACEUTICALS INC's Piotroski F-Score?
ANI PHARMACEUTICALS INC's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ANIP overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $107, ANIP appears undervalued. The stock currently trades 22% below its estimated fair value. Fair value above market price. P/E of 22x is moderate for this quality level.
How does ANIP compare to other Health Care stocks?
ANI PHARMACEUTICALS INC ranks #439 out of 1121 stocks in the Health Care sector, placing it in the top 39% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about ANIP?
AlphaStocks evaluates ANIP using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Caution; Lynch: Strong; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.3/10.

Similar Stocks

PARRBFAMAZN

Compare ANIP with

ANIP vs PARRANIP vs BFAMANIP vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer